Now, we’re about to publish the first study looking at the effects of this program on prostate cancer, and, in collaboration with Sloane-Kettering and with UCSF. We took 90 men who had biopsy-proven prostate cancer and who had elected, for reasons unrelated to the study, not to have surgery.
Suntem pe cale de a publica primul studiu care analizeaza efectele acestui program asupra cancerului la prostata; impreuna cu Sloane-Kettering  si Universitatea din Califonia am facut studiul pe 90 de barbati care au fost identificati cu cancer la prostata si care au ales din motive personale sa nu faca operatie.